Semaglutide, commonly marketed under the brand name Ozempic, is a medication used primarily for the treatment of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking the incretin hormones that the body usually produces to stimulate insulin release in response to meals.
This not only helps to control blood sugar levels but also contributes to weight loss, making it a dual-benefit option for patients managing type 2 diabetes.
Knowing the source of the ingredients can inform healthcare providers and patients about the sustainability and ethical sourcing practices of the manufacturing process, aspects increasingly important to consumer choices and regulatory compliance in the pharmaceutical industry.